Brought to you by:
BioGenCell begins recruitment for clinical trial of stem cell-based treatment for preventing limb amputation
BioGenCell has announced that it is recruiting for an international clinical trial to assess the company’s stem cell-based therapy for chronic limb-threatening ischemia patients who are at risk for limb amputation. The clinical trial is currently taking place in medical…
SVS DEI Committee launches ‘Voices of Vascular’ series
To help celebrate the diversity in the vascular surgery specialty, the Society for Vascular Surgery Diversity, Equity and Inclusion Committee has launched “Voices of Vascular,” a series highlighting the contributions of surgeons from a wide variety of backgrounds. “Voices” debuts…
More than a research project: The vascular trainee’s role in tackling disparities in peripheral arterial disease
One of my earliest clinical experiences with vascular disease was as a high school student shadowing at a busy urban hospital in Detroit. A Black man with a longstanding history of diabetes developed a foot ulcer that ultimately required an…
March’s free-access articles in JVS, JVS-VL
The March issues of the Journal of Vascular Surgery (JVS) and JVS: Venous and Lymphatic Disorders (JVS-VL) include eight articles that will be available via free-access by Feb. 21 (JVS-VL) and Feb. 23 (JVS). The fully accessible peer-review papers are…
VAM 2023 meeting set to take place as exclusively in-person event
A block party on opening day, session recordings available daily and—of course—the educational and scientific sessions for which the Society for Vascular Surgery’s Vascular Annual Meeting (VAM) is known: all this and much more will be part of VAM 2023.…
Strategic planning session outlines SVS priorities for coming year
Key leaders from the society for Vascular Surgery (SVS) gathered in mid-January for a two-day Strategic Board of Directors (SBOD) meeting to work through the Society’s six strategic domains. SVS Executive Director Kenneth M. Slaw, PhD, noted, “The SBOD provides…
Likes, dislikes and reposts: The new age of the vascular surgery influencer
The brave new world of social media, with its TikToks and Kardashians, has now invaded our once-sane specialty. No, this is not a veiled reference to controversial swim attire events in our past, but rather a totally new phenomenon. Whether…
The case for aggressive intervention on symptomatic carotid web
The lead investigator behind new research from a center in Louisiana outlines how his new study—believed to be the largest single-institution analysis of symptomatic carotid web yet reported—shows that carotid duplex is “inadequate” for diagnosis, and medical management is “unacceptable.”…
New Government Grand Rounds series highlights how perspective matters in advocacy
Matthew Sideman, MD, and Megan Marcinko, MPS, unveil new advocacy column aimed at drilling into the actions of Congress, and how they impact vascular surgery. The first in the series looks at advocacy as a tool to “protect.” Welcome to…
Biotronik launches Oscar multifunctional peripheral catheter
Biotronik has announced the Food and Drug Administration (FDA) 510(k) clearance and CE mark of its Oscar (One Solution: Cross. Adjust. Restore) multifunctional peripheral catheter. The company notes in a press release that Oscar is intended for percutaneous transluminal interventions…